+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Advanced Wound Care Market by Product, Application and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • ID: 5157226
  • Report
  • August 2020
  • Region: Global
  • 261 pages
  • Allied Analytics LLP

Enquire about COVID-19 updates for this product.

Enquire Now
The advanced wound care market was valued at $9,255.70 million in 2019, and is estimated to reach at $15,305.94 million by 2027, registering a CAGR of 11.6% from 2020 to 2027. The wound healing process can be facilitated in two different ways, including traditional wound care (TWC) and advanced wound care (AWC). Chronic wounds take more time to heal and are expensive to treat. Thus, advanced wound care is developing as a standard solution for treating chronic wounds. Moreover, traditional wound care products such as hydrocolloids, hydrogels, film & foam dressings, and alginates are being increasingly replaced with advanced wound care products, due to their enhanced efficiency & effectiveness in managing wounds by enabling rapid healing. Moreover, they offer various advantages such as they aid to maintain a hydrated environment for appropriate flow of oxygen, keep temperature consistent, protect the wound site from exogenous infection, and ease pain associated with dressing changes.

Significant increase in prevalence of chronic diseases such as diabetes & obesity, rise in geriatric population, technological advancements in advanced wound care products, problems associated with traditional wound healing methods, and surge in adoption of evidence-based treatments such as silver dressings, hyperbaric oxygen, electrotherapy, and ultrasound for chronic wounds are the key factors that fuel the growth of the advanced wound care market. Moreover, rise in awareness programs for advanced wound care treatment & management, attempts to reduce the duration of the hospital stay to lower healthcare expenses, and rise in inclination toward wound care products that enhance therapeutic outcomes are other factors that contribute toward the growth of the market. However, high cost associated with advanced wound care products are expected to hinder the growth of the market.

The advanced wound care market is segmented into product, application, end user, and region. By product, the market is categorized into infection management, exudate management, active wound care, and therapy devices. Infection management is sub segmented into silver dressings, non-silver dressings, and collagens. The exudate management segment is further divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. The active wound care is subdivided into skin substitutes and growth factors. The therapy devices is further segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others. The applications covered in the study include chronic wounds and acute wounds. The chronic wounds segment is further segregated into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The acute wounds is further fragmented into burns & trauma, and surgical wounds. Depending on end user, the market is classified into hospitals and community health service centers. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, Coloplast A/S, ConvaTec Group Plc, Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic Plc., Organogenesis Holdings Inc., and Smith & Nephew Plc.

Key Benefits for Stakeholders
  • The study provides an in-depth analysis of the global advanced wound care market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of advanced wound cis used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Key Market Segments

By Product type
  • Infection Management
  • Silver Wound Dressings
  • Non-silver Dressings
  • Collagen Dressings
  • Exudate Management
  • Hydrocolloids Dressings
  • Foam Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Active Wound Care
  • Skin Substitutes
  • Growth Factors
  • Therapy Devices
  • Negative Pressure Wound Therapy (NPWT)
  • Oxygen and Hyperbaric Oxygen Equipment
  • Electromagnetic Therapy Devices
  • Others
By Application
  • Chronic Wounds
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Arterial Ulcers
  • Acute Wounds
  • Burns & Trauma
  • Surgical Wounds
By End User
  • Hospitals
  • Community Health Service Centers
By Region

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • 3M (Acelity Inc.)
  • Adynxx, Inc
  • B Braun Melsungen AG
  • Coloplast A/S
  • ConvaTec Group plc
  • Essity AB (BSN Medical GmbH)
  • Integra Lifesciences (Derma sciences)
  • Investor AB (Mölnlycke Health Care AB)
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic plc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc.
Note: Product cover images may vary from those shown
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’S Five Force Analysis
3.4. Market Share Analysis
3.4.1. Drivers
3.4.1.1. Rise in Geriatric Population
3.4.1.2. Upsurge in Incidences of Diabetes, Obesity, and Chronic Conditions
3.4.1.3. Technological Advancements to Deal With Complex Wounds
3.4.2. Restrains
3.4.2.1. High Cost of Advanced Wound Care Products
3.4.3. Opportunities
3.4.3.1. Untapped Opportunities in Developing Economies
3.5. Market Dynamics
3.6. Covid-19 Impact on the Market

Chapter 4: Advanced Wound Care Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Infection Management
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.2.4. Market Size and Forecast, by Type
4.2.5. Silver Wound Dressings
4.2.5.1. Market Size and Forecast
4.2.6. Non-Silver Dressings
4.2.6.1. Market Size and Forecast
4.2.7. Collagen Dressings
4.2.7.1. Market Size and Forecast
4.3. Exudate Management
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.3.4. Market Size and Forecast, by Product
4.3.5. Hydrocolloid Dressings
4.3.5.1. Market Size and Forecast
4.3.6. Foam Dressings
4.3.6.1. Market Size and Forecast
4.3.7. Alginate Dressings
4.3.7.1. Market Size and Forecast
4.3.8. Hydrogel Dressings
4.3.8.1. Market Size and Forecast
4.4. Active Wound Care
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
4.4.4. Market Size and Forecast, by Type
4.4.5. Skin Substitutes
4.4.5.1. Market Size and Forecast
4.4.6. Growth Factors
4.4.6.1. Market Size and Forecast
4.5. Therapy Devices
4.5.1. Key Market Trends, Growth Factors, and Opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Analysis, by Country
4.5.4. Market Size and Forecast, by Type
4.5.5. Negative Pressure Wound Therapy (Npwt)
4.5.5.1. Market Size and Forecast
4.5.6. Oxygen & Hyperbaric Oxygen Equipment
4.5.6.1. Market Size and Forecast
4.5.7. Electromagnetic Therapy Devices
4.5.7.1. Market Size and Forecast
4.5.8. Others
4.5.8.1. Market Size and Forecast

Chapter 5: Advanced Wound Care Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Chronic Wounds
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.2.3. Market Size and Forecast, by Type
5.2.4. Pressure Ulcers
5.2.4.1. Market Size and Forecast
5.2.5. Diabetic Foot Ulcers
5.2.5.1. Market Size and Forecast
5.2.6. Venous Leg Ulcers
5.2.6.1. Market Size and Forecast
5.2.7. Arterial Ulcers
5.2.7.1. Market Size and Forecast
5.3. Acute Wounds
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
5.3.3. Market Size and Forecast, by Type
5.3.4. Burns & Trauma
5.3.4.1. Market Size and Forecast
5.3.5. Surgical Wounds
5.3.5.1. Market Size and Forecast

Chapter 6: Advanced Wound Care Market, by End-user
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Hospitals
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. Community Health Service Centers
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country

Chapter 7: Advanced Wound Care Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Country
7.2.2.1. U.S. Advanced Wound Care Market, by Product
7.2.2.2. U.S. Advanced Wound Care Market, by Application
7.2.2.3. U.S. Advanced Wound Care Market, by End-user
7.2.2.4. Mexico Advanced Wound Care Market, by Product
7.2.2.5. Mexico Advanced Wound Care Market, by Application
7.2.2.6. Mexico Advanced Wound Care Market, by End-user
7.2.2.7. Canada Advanced Wound Care Market, by Product
7.2.2.8. Canada Advanced Wound Care Market, by Application
7.2.2.9. Canada Advanced Wound Care Market, by End-user
7.2.3. North America Market Size and Forecast, by Product
7.2.4. North America Market Size and Forecast, by Application
7.2.5. North America Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Country
7.3.2.1. Germany Advanced Wound Care Market, by Product
7.3.2.2. Germany Advanced Wound Care Market, by Application
7.3.2.3. Germany Advanced Wound Care Market, by End-user
7.3.2.4. UK Advanced Wound Care Market, by Product
7.3.2.5. UK Advanced Wound Care Market, by Application
7.3.2.6. UK Advanced Wound Care Market, by End-user
7.3.2.7. France Advanced Wound Care Market, by Product
7.3.2.8. France Advanced Wound Care Market, by Application
7.3.2.9. France Advanced Wound Care Market, by End-user
7.3.2.10. Italy Advanced Wound Care Market, by Product
7.3.2.11. Italy Advanced Wound Care Market, by Application
7.3.2.12. Italy Advanced Wound Care Market, by End-user
7.3.2.13. Spain Advanced Wound Care Market, by Product
7.3.2.14. Spain Advanced Wound Care Market, by Application
7.3.2.15. Spain Advanced Wound Care Market, by End-user
7.3.2.16. Rest of Europe Advanced Wound Care Market, by Product
7.3.2.17. Rest of Europe Advanced Wound Care Market, by Application
7.3.2.18. Rest of Europe Advanced Wound Care Market, by End-user
7.3.3. Europe Market Size and Forecast, by Product
7.3.4. Europe Market Size and Forecast, by Application
7.3.5. Europe Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Country
7.4.2.1. Japan Advanced Wound Care Market, by Product
7.4.2.2. Japan Advanced Wound Care Market, by Application
7.4.2.3. Japan Advanced Wound Care Market, by End-user
7.4.2.4. China Advanced Wound Care Market, by Product
7.4.2.5. China Advanced Wound Care Market, by Application
7.4.2.6. China Advanced Wound Care Market, by End-user
7.4.2.7. India Advanced Wound Care Market, by Product
7.4.2.8. India Advanced Wound Care Market, by Application
7.4.2.9. India Advanced Wound Care Market, by End-user
7.4.2.10. Rest of Asia-Pacific Advanced Wound Care Market, by Product
7.4.2.11. Rest of Asia-Pacific Advanced Wound Care Market, by Application
7.4.2.12. Rest of Asia-Pacific Advanced Wound Care Market, by End-user
7.4.3. Asia-Pacific Market Size and Forecast, by Product
7.4.4. Asia-Pacific Market Size and Forecast, by Application
7.4.5. Asia-Pacific Market Size and Forecast, by End-user
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Country
7.5.2.1. Brazil Advanced Wound Care Market, by Product
7.5.2.2. Brazil Advanced Wound Care Market, by Application
7.5.2.3. Brazil Advanced Wound Care Market, by End-user
7.5.2.4. Saudi Arabia Advanced Wound Care Market, by Product
7.5.2.5. Saudi Arabia Advanced Wound Care Market, by Application
7.5.2.6. Saudi Arabia Advanced Wound Care Market, by End-user
7.5.2.7. South Africa Advanced Wound Care Market, by Product
7.5.2.8. South Africa Advanced Wound Care Market, by Application
7.5.2.9. South Africa Advanced Wound Care Market, by End-user
7.5.2.10. Rest of LAMEA Advanced Wound Care Market, by Product
7.5.2.11. Rest of LAMEA Advanced Wound Care Market, by Application
7.5.2.12. Rest of LAMEA Advanced Wound Care Market, by End-user
7.5.3. LAMEA Market Size and Forecast, by Product
7.5.4. LAMEA Market Size and Forecast, by Application
7.5.5. LAMEA Market Size and Forecast, by End-user

Chapter 8: Company Profiles
8.1.3M (Acelity Inc.)
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves and Developments
8.2. Adynxx, Inc.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Key Strategic Moves and Developments
8.3. B. Braun Melsungen AG
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.4. Coloplast A/S
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.5. Convatec Group plc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.6. Essity Ab (Bsn Medical Gmbh)
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves and Developments
8.7. Integra Lifesciences Holdings Corporation (Derma Sciences)
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.7.6. Key Strategic Moves and Developments
8.8. Investor Ab (Mölnlycke Health Care Ab)
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves and Developments
8.9. Johnson & Johnson
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Medline Industries, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.11. Medtronic plc.
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Operating Business Segments
8.11.4. Product Portfolio
8.11.5. Business Performance
8.12. Organogenesis Holdings Inc.
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Operating Business Segments
8.12.4. Product Portfolio
8.12.5. Business Performance
8.13. Smith & Nephew plc.
8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Operating Business Segments
8.13.4. Product Portfolio
8.13.5. Business Performance
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll